{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "G",
          "position": "1441"
        },
        "variant_string_id": "LRRK2 R1441G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that LRRK2 mutations cause PD, and the pathogenic mechanism involves reduced phosphorylation of S935 and impaired 14-3-3 binding.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links LRRK2 mutations to PD pathogenesis via phosphorylation and protein interaction defects."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses phosphorylation assays, 14-3-3 binding assays, and PKA inhibition experiments to assess LRRK2 function.",
          "judgment": "Yes",
          "reasoning": "Phosphorylation and protein interaction assays are standard for studying kinase function and disease mechanisms.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Controls included wild-type LRRK2 and PD-related mutations. Replicates were implied through multiple tissue/age groups and isoform-specific experiments.",
          "judgment": "Yes",
          "reasoning": "Wild-type and mutant controls were used, but explicit replication details (e.g., n=3) are absent. Assays are broadly accepted in the field.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "R1441G reduces S935 phosphorylation and 14-3-3 binding. No OddsPath calculation is provided.",
          "judgment": "Yes",
          "reasoning": "The variant directly disrupts phosphorylation and binding, key functional metrics. Statistical analysis is absent, but mechanistic evidence is strong.",
          "next_step_or_outcome": "Assign PS3_supporting"
        }
      ],
      "functional_evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Y",
          "alt": "C",
          "position": "1699"
        },
        "variant_string_id": "LRRK2 Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that LRRK2 mutations cause PD, and the pathogenic mechanism involves reduced phosphorylation of S935 and impaired 14-3-3 binding.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links LRRK2 mutations to PD pathogenesis via phosphorylation and protein interaction defects."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses phosphorylation assays, 14-3-3 binding assays, and PKA inhibition experiments to assess LRRK2 function.",
          "judgment": "Yes",
          "reasoning": "Phosphorylation and protein interaction assays are standard for studying kinase function and disease mechanisms.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Controls included wild-type LRRK2 and PD-related mutations. Replicates were implied through multiple tissue/age groups and isoform-specific experiments.",
          "judgment": "Yes",
          "reasoning": "Wild-type and mutant controls were used, but explicit replication details (e.g., n=3) are absent. Assays are broadly accepted in the field.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Y1699C reduces S935 phosphorylation and 14-3-3 binding. No OddsPath calculation is provided.",
          "judgment": "Yes",
          "reasoning": "The variant directly disrupts phosphorylation and binding, key functional metrics. Statistical analysis is absent, but mechanistic evidence is strong.",
          "next_step_or_outcome": "Assign PS3_supporting"
        }
      ],
      "functional_evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that LRRK2 mutations cause PD, and the pathogenic mechanism involves reduced phosphorylation of S935 and impaired 14-3-3 binding.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links LRRK2 mutations to PD pathogenesis via phosphorylation and protein interaction defects."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses phosphorylation assays, 14-3-3 binding assays, and PKA inhibition experiments to assess LRRK2 function.",
          "judgment": "Yes",
          "reasoning": "Phosphorylation and protein interaction assays are standard for studying kinase function and disease mechanisms.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Controls included wild-type LRRK2 and PD-related mutations. Replicates were implied through multiple tissue/age groups and isoform-specific experiments.",
          "judgment": "Yes",
          "reasoning": "Wild-type and mutant controls were used, but explicit replication details (e.g., n=3) are absent. Assays are broadly accepted in the field.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "G2019S reduces S935 phosphorylation and 14-3-3 binding. No OddsPath calculation is provided.",
          "judgment": "Yes",
          "reasoning": "The variant directly disrupts phosphorylation and binding, key functional metrics. Statistical analysis is absent, but mechanistic evidence is strong.",
          "next_step_or_outcome": "Assign PS3_supporting"
        }
      ],
      "functional_evidence_strength": "PS3_supporting"
    }
  ]
}